Exploration of the source of AQP4 antibody: Based on paired serum and cerebrospinal fluid samples from 98 patients
- 13 February 2026
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 586, 120906
Abstract
No abstract availableKeywords
Funding Information
- Peking University First Hospital
- China Postdoctoral Science Foundation (2025M772307)
This publication has 46 references indexed in Scilit:
- Influencing factors and clinical value of anti-aquaporin-4 antibody in cerebrospinal fluid: a study of 82 patients with neuromyelitis optica spectrum disorderActa Neurologica Belgica, 2025
- Differences in clinical phenotype, laboratory, and imaging manifestations between AQP4 IgG positive and AQP4 MOG IgG double negative NMOSD: How to correctly diagnose the twoAutoimmunity Reviews, 2025
- Distinguishing Neuromyelitis Optica Spectrum Disorders Subtypes: A Study on AQP4 and C3d Epitope Expression in Cytokine‐Primed Human AstrocytesGlia, 2025
- A comprehensive review of the advances in neuromyelitis optica spectrum disorderAutoimmunity Reviews, 2023
- Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosisJournal of Neurology, 2023
- CNS Aquaporin‐4‐specific B cells connect with multiple B‐cell compartments in neuromyelitis optica spectrum disorderAnnals of Clinical and Translational Neurology, 2017
- Cerebrospinal fluid aquaporin‐4‐immunoglobulin G disrupts blood brain barrierAnnals of Clinical and Translational Neurology, 2015
- Cerebrospinal fluid aquaporin‐4 antibody levels in neuromyelitis optica attacksAnnals of Neurology, 2014
- Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis opticaAnnals of Neurology, 2009
- Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous systemClinica Chimica Acta, 1987